✨ Your Portfolio is fetched and updated from zerodha.
Pharmaceuticals
Market Cap
₹0 Cr.
P/E
0.00

Insufficient data

FAQs on Earkart Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Earkart is 0

Growth Table
  • Earkart Ltd.
  • Osel Devices
Balance Sheet
  • Earkart Ltd.
  • Osel Devices
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Earkart Ltd.
  • Osel Devices
Cash Flow
  • Earkart Ltd.
  • Osel Devices
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Earkart Ltd.
  • Osel Devices
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Earkart Ltd. Financials

Earkart balance sheet is weak and might have solvency issues

Yes, The net debt of Earkart is increasing.
Latest net debt of Earkart is ₹1.26 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹0.05 Crs.

Yes, profit is increasing.
The profit of Earkart is ₹3.06 Crs for Mar 2024, ₹1.31 Crs for Mar 2023 and ₹0.11 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Earkart latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech